551 related articles for article (PubMed ID: 19726976)
21. Clinical significance of alphaII-spectrin breakdown products in cerebrospinal fluid after severe traumatic brain injury.
Pineda JA; Lewis SB; Valadka AB; Papa L; Hannay HJ; Heaton SC; Demery JA; Liu MC; Aikman JM; Akle V; Brophy GM; Tepas JJ; Wang KK; Robertson CS; Hayes RL
J Neurotrauma; 2007 Feb; 24(2):354-66. PubMed ID: 17375999
[TBL] [Abstract][Full Text] [Related]
22. Utility of Serum Biomarkers in the Diagnosis and Stratification of Mild Traumatic Brain Injury.
Lewis LM; Schloemann DT; Papa L; Fucetola RP; Bazarian J; Lindburg M; Welch RD
Acad Emerg Med; 2017 Jun; 24(6):710-720. PubMed ID: 28170122
[TBL] [Abstract][Full Text] [Related]
23. Serum concentrations of ubiquitin C-terminal hydrolase-L1 and αII-spectrin breakdown product 145 kDa correlate with outcome after pediatric TBI.
Berger RP; Hayes RL; Richichi R; Beers SR; Wang KK
J Neurotrauma; 2012 Jan; 29(1):162-7. PubMed ID: 22022780
[TBL] [Abstract][Full Text] [Related]
24. UCH-L1 is a Poor Serum Biomarker of Murine Traumatic Brain Injury After Polytrauma.
Morris MC; Bercz A; Niziolek GM; Kassam F; Veile R; Friend LA; Pritts TA; Makley AT; Goodman MD
J Surg Res; 2019 Dec; 244():63-68. PubMed ID: 31279265
[TBL] [Abstract][Full Text] [Related]
25. Serum GFAP and UCH-L1 for prediction of absence of intracranial injuries on head CT (ALERT-TBI): a multicentre observational study.
Bazarian JJ; Biberthaler P; Welch RD; Lewis LM; Barzo P; Bogner-Flatz V; Gunnar Brolinson P; Büki A; Chen JY; Christenson RH; Hack D; Huff JS; Johar S; Jordan JD; Leidel BA; Lindner T; Ludington E; Okonkwo DO; Ornato J; Peacock WF; Schmidt K; Tyndall JA; Vossough A; Jagoda AS
Lancet Neurol; 2018 Sep; 17(9):782-789. PubMed ID: 30054151
[TBL] [Abstract][Full Text] [Related]
26. Performance of glial fibrillary acidic protein (GFAP) and ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) biomarkers in predicting CT scan results and neurological outcomes in children with traumatic brain injury (BRAINI-2 paediatric study): protocol of a European prospective multicentre study.
Lorton F; Lagares A; de la Cruz J; Méjan O; Pavlov V; Sapin V; Poca MA; Lehner M; Biberthaler P; Chauviré-Drouard A; Gras-Le-Guen C; Scherdel P; ;
BMJ Open; 2024 May; 14(5):e083531. PubMed ID: 38754888
[TBL] [Abstract][Full Text] [Related]
27. Serum Concentrations of Ubiquitin C-Terminal Hydrolase-L1 and Glial Fibrillary Acidic Protein after Pediatric Traumatic Brain Injury.
Mondello S; Kobeissy F; Vestri A; Hayes RL; Kochanek PM; Berger RP
Sci Rep; 2016 Jun; 6():28203. PubMed ID: 27319802
[TBL] [Abstract][Full Text] [Related]
28. Pentobarbital coma for refractory intra-cranial hypertension after severe traumatic brain injury: mortality predictions and one-year outcomes in 55 patients.
Marshall GT; James RF; Landman MP; O'Neill PJ; Cotton BA; Hansen EN; Morris JA; May AK
J Trauma; 2010 Aug; 69(2):275-83. PubMed ID: 20699736
[TBL] [Abstract][Full Text] [Related]
29. Ubiquitin carboxy-terminal hydrolase L1 (UCH-L1) is increased in cerebrospinal fluid and plasma of patients after epileptic seizure.
Mondello S; Palmio J; Streeter J; Hayes RL; Peltola J; Jeromin A
BMC Neurol; 2012 Aug; 12():85. PubMed ID: 22931063
[TBL] [Abstract][Full Text] [Related]
30. Acute Temporal Profiles of Serum Levels of UCH-L1 and GFAP and Relationships to Neuronal and Astroglial Pathology following Traumatic Brain Injury in Rats.
Huang XJ; Glushakova O; Mondello S; Van K; Hayes RL; Lyeth BG
J Neurotrauma; 2015 Aug; 32(16):1179-89. PubMed ID: 25763798
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic Utility of Glial Fibrillary Acidic Protein Beyond 12 Hours After Traumatic Brain Injury: A TRACK-TBI Study.
Puccio AM; Yue JK; Korley FK; Okonkwo DO; Diaz-Arrastia R; Yuh EL; Ferguson AR; Mukherjee P; Wang KKW; Taylor SR; Deng H; Markowitz AJ; Sun X; Jain S; Manley GT
J Neurotrauma; 2024 Jun; 41(11-12):1353-1363. PubMed ID: 38251868
[TBL] [Abstract][Full Text] [Related]
32. Glial fibrillary acidic protein is highly correlated with brain injury.
Lumpkins KM; Bochicchio GV; Keledjian K; Simard JM; McCunn M; Scalea T
J Trauma; 2008 Oct; 65(4):778-82; discussion 782-4. PubMed ID: 18849790
[TBL] [Abstract][Full Text] [Related]
33. Screening Performance of S100 Calcium-Binding Protein B, Glial Fibrillary Acidic Protein, and Ubiquitin C-Terminal Hydrolase L1 for Intracranial Injury Within Six Hours of Injury and Beyond.
Trivedi D; Forssten MP; Cao Y; Ismail AM; Czeiter E; Amrein K; Kobeissy F; Wang KKW; DeSoucy E; Buki A; Mohseni S
J Neurotrauma; 2024 Feb; 41(3-4):349-358. PubMed ID: 38115670
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of Acute Glial Fibrillary Acidic Protein and Ubiquitin C-Terminal Hydrolase-L1 Plasma Levels in Traumatic Brain Injury Patients with and without Intracranial Lesions.
Biberthaler P; Musaelyan K; Krieg S; Meyer B; Stimmer H; Zapf J; von Matthey F; Chandran R; Marino JA; Beligere G; Hoffmann M; Zhang H; Datwyler SA; McQuiston B
Neurotrauma Rep; 2021; 2(1):617-625. PubMed ID: 35018363
[TBL] [Abstract][Full Text] [Related]
35. Prognostic Value of Serum Biomarkers in Patients With Moderate-Severe Traumatic Brain Injury, Differentiated by Marshall Computer Tomography Classification.
Richter S; Czeiter E; Amrein K; Mikolic A; Verheyden J; Wang K; Maas AIR; Steyerberg E; Büki A; Menon DK; Newcombe VFJ
J Neurotrauma; 2023 Nov; 40(21-22):2297-2310. PubMed ID: 37376742
[TBL] [Abstract][Full Text] [Related]
36. Association of Very Early Serum Levels of S100B, Glial Fibrillary Acidic Protein, Ubiquitin C-Terminal Hydrolase-L1, and Spectrin Breakdown Product with Outcome in ProTECT III.
Frankel M; Fan L; Yeatts SD; Jeromin A; Vos PE; Wagner AK; Wolf BJ; Pauls Q; Lunney M; Merck LH; Hall CL; Palesch YY; Silbergleit R; Wright DW
J Neurotrauma; 2019 Oct; 36(20):2863-2871. PubMed ID: 30794101
[TBL] [Abstract][Full Text] [Related]
37. The diagnostic values of UCH-L1 in traumatic brain injury: A meta-analysis.
Shahjouei S; Sadeghi-Naini M; Yang Z; Kobeissy F; Rathore D; Shokraneh F; Blackburn S; Manley GT; Wang KKW
Brain Inj; 2018; 32(1):1-17. PubMed ID: 29087740
[TBL] [Abstract][Full Text] [Related]
38. αII-spectrin breakdown products (SBDPs): diagnosis and outcome in severe traumatic brain injury patients.
Mondello S; Robicsek SA; Gabrielli A; Brophy GM; Papa L; Tepas J; Robertson C; Buki A; Scharf D; Jixiang M; Akinyi L; Muller U; Wang KK; Hayes RL
J Neurotrauma; 2010 Jul; 27(7):1203-13. PubMed ID: 20408766
[TBL] [Abstract][Full Text] [Related]
39. Glial neuronal ratio: a novel index for differentiating injury type in patients with severe traumatic brain injury.
Mondello S; Jeromin A; Buki A; Bullock R; Czeiter E; Kovacs N; Barzo P; Schmid K; Tortella F; Wang KK; Hayes RL
J Neurotrauma; 2012 Apr; 29(6):1096-104. PubMed ID: 22165978
[TBL] [Abstract][Full Text] [Related]
40. Association between Blood and Computed Tomographic Imaging Biomarkers in a Cohort of Mild Traumatic Brain Injury Patients.
Chen H; Ding VY; Zhu G; Jiang B; Li Y; Boothroyd D; Rezaii PG; Bet AM; Paulino AD; Weber A; Glushakova OY; Hayes RL; Wintermark M
J Neurotrauma; 2022 Oct; 39(19-20):1329-1338. PubMed ID: 35546284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
